Gossamer Bio, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for GOSS, updated each market day.
GOSS AI Sentiment
AI sees no strong directional signal for Gossamer Bio, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Gossamer Bio, Inc. Common Stock
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Sector
Exchange
Market Cap
$87,213,138
Cap Tier
Employees
162
Headquarters
SAN DIEGO, CA
Listed Since
Feb. 8, 2019
Website
GOSS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
GOSS Volatility
Gossamer Bio, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
